Nitnib 12.5 mg Capsule
5,61$
4,37$
Nitnib 12.5 mg capsules are a targeted anticancer therapy designed to combat various malignancies, including pancreatic cancer, gastrointestinal stromal tumors, and renal cell carcinoma. This innovative medication works by inhibiting the proliferation of cancer cells, thereby slowing tumor growth and progression. By effectively blocking specific signals that cancer cells rely on for survival, Nitnib helps to enhance the overall treatment outcome for patients facing these challenging diagnoses. While using Nitnib, it's essential to monitor for potential side effects, which may include fatigue, nausea, and changes in liver function, underscoring the need for regular medical supervision. Patients should also be aware of contraindications and discuss their complete medical history with healthcare providers before starting this medication. As a vital part of a comprehensive cancer treatment plan, Nitnib 12.5 mg capsules offer hope and a pathway to improved quality of life for those affected by these aggressive cancers. Always consult your healthcare professional for personalized advice and to ensure the safe and effective use of this medication.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Nitnib 12 5 mg capsule is primarily indicated for the treatment of Advanced Renal Cell Carcinoma (RCC). This form of kidney cancer arises from the cells in the kidney's small tubes. By targeting specific pathways involved in tumor growth, Nitnib 12 5 mg capsule can help manage the disease effectively. It is often utilized in advanced stages where other treatment options may have been exhausted.
• The medicine is also used for the management of Gastrointestinal Stromal Tumor (GIST). GIST is a rare cancer that develops in the digestive tract, particularly within the stomach or small intestine. Nitnib 12 5 mg capsule works by inhibiting certain proteins that promote cancer cell proliferation. This targeted approach can improve treatment outcomes for patients diagnosed with GIST.
• Another application of Nitnib 12 5 mg capsule is in the treatment of Pancreatic Neuroendocrine Tumors (PNETs). These tumors originate from the endocrine cells of the pancreas and are less common than other pancreatic cancers. Nitnib 12 5 mg capsule assists in controlling the growth of these tumors by interfering with specific signaling pathways. This makes it a valuable option for patients dealing with PNETs.
Benefits
Nitnib 12.5 Capsule is used to treat specific forms of cancer, such as gastrointestinal stromal tumors (GISTs), renal cell carcinoma (RCC), and imatinib-resistant GIST. The advantages of using Nitnib may involve reducing the size of cancerous tumors, slowing the progression and spread of cancer, alleviating cancer-related symptoms, and potentially extending survival in some individuals.
Side Effects
Like all medicines, Nitnib 12.5 mg Capsule may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Complete or Partial hair loss
• Change in hair and skin colour
• Back pain
• Stomach upset
• Dry skin
• Diarrhea
• Swollen eyes
• Tingling sensation in limbs
• Nausea and Vomiting
• Tiredness
• Muscle spasms
Common Side Effects
• Headache
• Blistered palm
• Rashes
• Sores mouth or tongue
• Bleeding
• Swollen and Painful limbs
• decreased vision
• Blood in stool
• Fast heartbeat
• Sweating
• Hypertension
• Panful urination
• Unusual weight gain
• Trouble breathing
• serious side effects
• Dizziness
• Fatal skin reaction
How To Use
You may take this medicine with or without a meal. It is recommended that you swallow the tablet whole with a full glass of water and that you do not crush, chew, or break the tablet. If you miss a dose of this medicine, take it as soon as you can. Skip the missed dose and return to your regular dosing schedule if it is almost time for your next dose. Do not take a double dose of your medicine to make up for a missed dose.
Safety Advice
• Alcohol: Drinking alcohol while taking Nitnib 12.5 mg is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Nitnib 12.5 Capsule in patients with kidney disease. No dose adjustment of Nitnib 12.5 mg Capsule is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Nitnib 12.5 mg. Nitnib Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Nitnib, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Nitnib 12.5 Capsule is safe for use in patients with mild to moderate liver disease, no dose adjustment of Nitnib 12.5 mg Capsule is recommended. The use of Nitnib is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Nitnib 12.5 mg Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Nitnib 12.5 Capsule during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Nitnib Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Nitnib.